178 related articles for article (PubMed ID: 24065492)
1. Central lymph node metastasis in cN0 papillary thyroid carcinoma.
Wu Y; Gu J; Shang J; Wang W; Wang K
J BUON; 2013; 18(3):733-8. PubMed ID: 24065492
[TBL] [Abstract][Full Text] [Related]
2. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
4. Predictors of central lymph node metastasis in papillary thyroid cancer.
Celik H; Akgul O; Yıldız BD; Saylam B; Tez M
Ann Ital Chir; 2017; 88():193-197. PubMed ID: 28874622
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma.
Hu D; Zhou J; He W; Peng J; Cao Y; Ren H; Mao Y; Dou Y; Xiong W; Xiao Q; Su X
World J Surg Oncol; 2018 Feb; 16(1):30. PubMed ID: 29439716
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of central lymph node dissection for papillary thyroid carcinoma in cN0 T1/T2].
Zhao SY; Ma YH; Yin Z; Zhan XX; Cheng RC; Qian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):105-109. PubMed ID: 29429179
[No Abstract] [Full Text] [Related]
10. Right paraesophageal lymph node dissection in papillary thyroid carcinoma.
Bae SY; Yang JH; Choi MY; Choe JH; Kim JH; Kim JS
Ann Surg Oncol; 2012 Mar; 19(3):996-1000. PubMed ID: 22094496
[TBL] [Abstract][Full Text] [Related]
11. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
12. Central lymph node metastases in unilateral papillary thyroid microcarcinoma.
Lim YC; Choi EC; Yoon YH; Kim EH; Koo BS
Br J Surg; 2009 Mar; 96(3):253-7. PubMed ID: 19224514
[TBL] [Abstract][Full Text] [Related]
13. Performing contralateral central lymph node dissection in papillary thyroid carcinoma: a decision approach.
Chae BJ; Jung CK; Lim DJ; Song BJ; Kim JS; Jung SS; Bae JS
Thyroid; 2011 Aug; 21(8):873-7. PubMed ID: 21745104
[TBL] [Abstract][Full Text] [Related]
14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
15. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis.
Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Lee BJ
Ann Surg Oncol; 2011 Nov; 18(12):3486-92. PubMed ID: 21553141
[TBL] [Abstract][Full Text] [Related]
17. The total number of prelaryngeal and pretracheal lymph node metastases: is it a reliable predictor of contralateral central lymph node metastasis in papillary thyroid carcinoma?
Chen Q; Wei T; Wang XL; Li ZH; Du ZH; Zhu JQ
J Surg Res; 2017 Jun; 214():162-167. PubMed ID: 28624039
[TBL] [Abstract][Full Text] [Related]
18. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation.
Wada N; Sugino K; Mimura T; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Nakayama H; Hirakawa S; Yukawa N; Rino Y; Masuda M; Ito K
Ann Surg Oncol; 2009 Dec; 16(12):3442-9. PubMed ID: 19777194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
